From Criterion in The Australian today.... nothing we Biotans dont already know.
"Biota's deal is almost too good to be true, in that key motive of its new chum is to ensure Lani is available for its flu stockpile for the wellbeing of Americans."
"Hence, there's no commercial return such as a slab of Biota equity or ownership and manufacturing rights."
